The biological significance of nuclear BCL10 expression was further validated in tumor cells of patients with advanced, metastatic, and recurrent and/or metastatic PDAC after curative surgery, in which the nuclear BCL10 expression significantly correlated with nuclear NF-κB expression and poor OS (after commencing chemotherapy) of these patients. This evidence concerns the gene BCL10 and neoplasm.